Latest Alligator Bioscience News & Updates

See the latest news and media coverage for Alligator Bioscience. We track all announcements, press releases, and industry mentions in real time, all in one place.

Alligator Bioscience

Clinical-stage biotechnology company developing tumor-directed cancer immunotherapies

alligatorbioscience.se

Headquarters: Lund, Sweden
Founded year: 2001
Company type: Public company
Number of employees: 25–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Alligator Bioscience

In short: Alligator Bioscience refocused on its HLX22 project and raised SEK 125.6 million while discontinuing internal mitazalimab development.

Company announcements

July 23 Alligator Bioscience

Alligator Bioscience calls for extraordinary general meeting

The meeting will consider amendments to articles of association, share capital reduction, and a rights issue of units.

July 23 Alligator Bioscience

Alligator discontinues mitazalimab development and announces rights issue

The company refocuses on HLX22 project and raises approximately SEK 125.6 million via rights issue and bridge loans.

July 2 Alligator Bioscience

Alligator announces first patient dosed in early breast cancer study

The study evaluates intratumoral CD40 activation with or without nivolumab before surgery at an Ivy League university in the USA.

June 29 Alligator Bioscience

Alligator Bioscience has received external validation for mitazalimab

The OPTIMIZE-1 trial showed a 42.1% response rate and 14.9-month OS, with a unique priming strategy preconditioning the tumor microenvironment.

Media coverage

July 23 Yahoo Finance

Alligator Bioscience shares plunge 73% after abandoning its main drug

Investing.com - Alligator Bioscience shares plunged more than 73% on Thursday after the Swedish biotech announced it would discontinue the...

July 22 Morningstar

Alligator Discontinues Independent Development of Mitazalimab for a Strategic Refocus on the HLX22 Project, Announces a Rights Issue of Units of Approximately SEK 125.6 Million and Raises Bridge Loans | Morningstar

LUND, SE / ACCESS Newswire / July 23, 2026 / Alligator Bioscience (STO:ATORX) - The Board of Directors of Alligator Bioscience AB ("Alligator Bioscience" or...

July 6 Yahoo Finance

Alligator Bioscience AB (ATORX.ST) Q1 FY2026 earnings call transcript

Earnings call Alligator Bioscience delivered a steady Q1 2026, maintaining operating costs at SEK 17 million and securing SEK 90 million from warrant exercises, with...

July 2 Yahoo Finance

Alligator Announces First Patient Dosed in Investigator-Initiated Study of Intratumoral Mitazalimab in Early-Stage Breast Cancer

LUND, SE / ACCESS Newswire / July 2, 2026 / Alligator Bioscience (STO:ATORX) First patient dosed in an investigator-initiated trial evaluating intratumoral mitazalimab, with or...

Never miss news about Alligator Bioscience

Track Alligator Bioscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Alligator Bioscience competitors & trending companies

Browse news for competitors to Alligator Bioscience and other trending companies.